These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 35292418)
1. Transcriptional control of pancreatic β-cell identity and plasticity during the pathogenesis of type 2 diabetes. Zhang Z; Gao Y; Meng ZX J Genet Genomics; 2022 Apr; 49(4):316-328. PubMed ID: 35292418 [TBL] [Abstract][Full Text] [Related]
2. Klf6 protects β-cells against insulin resistance-induced dedifferentiation. Dumayne C; Tarussio D; Sanchez-Archidona AR; Picard A; Basco D; Berney XP; Ibberson M; Thorens B Mol Metab; 2020 May; 35():100958. PubMed ID: 32244185 [TBL] [Abstract][Full Text] [Related]
4. Loss of β-cell identity and dedifferentiation, not an irreversible process? Patel S; Remedi MS Front Endocrinol (Lausanne); 2024; 15():1414447. PubMed ID: 38915897 [TBL] [Abstract][Full Text] [Related]
5. PAX4 gene delivery improves β-cell function in human islets of Type II diabetes. Zhang Y; Parajuli KR; Fonseca VA; Wu H Regen Med; 2024 May; 19(5):239-246. PubMed ID: 39118533 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic β-cell identity, glucose sensing and the control of insulin secretion. Rutter GA; Pullen TJ; Hodson DJ; Martinez-Sanchez A Biochem J; 2015 Mar; 466(2):203-18. PubMed ID: 25697093 [TBL] [Abstract][Full Text] [Related]
7. Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans. Cinti F; Mezza T; Severi I; Suleiman M; Cefalo CMA; Sorice GP; Moffa S; Impronta F; Quero G; Alfieri S; Mari A; Pontecorvi A; Marselli L; Cinti S; Marchetti P; Giaccari A Metabolism; 2021 Jan; 114():154414. PubMed ID: 33129839 [TBL] [Abstract][Full Text] [Related]
8. Single-cell transcriptomics of human islet ontogeny defines the molecular basis of β-cell dedifferentiation in T2D. Avrahami D; Wang YJ; Schug J; Feleke E; Gao L; Liu C; ; Naji A; Glaser B; Kaestner KH Mol Metab; 2020 Dec; 42():101057. PubMed ID: 32739450 [TBL] [Abstract][Full Text] [Related]
9. β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity. Mezza T; Cinti F; Cefalo CMA; Pontecorvi A; Kulkarni RN; Giaccari A Diabetes; 2019 Jun; 68(6):1121-1129. PubMed ID: 31109941 [TBL] [Abstract][Full Text] [Related]
10. Reversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetes. Son J; Accili D Exp Mol Med; 2023 Aug; 55(8):1652-1658. PubMed ID: 37524865 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes. Cui D; Feng X; Lei S; Zhang H; Hu W; Yang S; Yu X; Su Z Chin Med J (Engl); 2024 Apr; 137(7):791-805. PubMed ID: 38479993 [TBL] [Abstract][Full Text] [Related]
12. Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes. Moin ASM; Butler AE Curr Diab Rep; 2019 Aug; 19(9):83. PubMed ID: 31401713 [TBL] [Abstract][Full Text] [Related]
13. β-Cell dysfunction in diabetes: a crisis of identity? Brereton MF; Rohm M; Ashcroft FM Diabetes Obes Metab; 2016 Sep; 18 Suppl 1(Suppl 1):102-9. PubMed ID: 27615138 [TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets. Bacos K; Perfilyev A; Karagiannopoulos A; Cowan E; Ofori JK; Bertonnier-Brouty L; Rönn T; Lindqvist A; Luan C; Ruhrmann S; Ngara M; Nilsson Å; Gheibi S; Lyons CL; Lagerstedt JO; Barghouth M; Esguerra JL; Volkov P; Fex M; Mulder H; Wierup N; Krus U; Artner I; Eliasson L; Prasad RB; Cataldo LR; Ling C J Clin Invest; 2023 Feb; 133(4):. PubMed ID: 36656641 [TBL] [Abstract][Full Text] [Related]
16. Protein Kinases Signaling in Pancreatic Beta-cells Death and Type 2 Diabetes. Engin AB; Engin A Adv Exp Med Biol; 2021; 1275():195-227. PubMed ID: 33539017 [TBL] [Abstract][Full Text] [Related]